Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Neurogastroenterology and Motility|September 11, 2004
Preclinical studies of opioids and opioid antagonists on gastrointestinal functionB Greenwood-Van Meerveld, C J Gardner, P J Little, et al.British Journal of Pharmacology|October 2, 1998
Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonistL Grélot, J Dapzol, E Estève, et al.Microbiology (Reading, England)|September 7, 2000
Suppression of sorbitol dependence in a strain bearing a mutation in the SRB1/PSA1/VIG9 gene encoding GDP-mannose pyrophosphorylase by PDE2 overexpression suggests a role for the Ras/cAMP signal-transduction pathway in the control of yeast cell-wall biogenesisGregory C Tomlin, Grant E Hamilton, David C J Gardner, et al.Oncology|June 1, 1996
Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugsC Bountra, J D Gale, C J Gardner, et al.Journal of the American College of Cardiology|November 1, 1992
Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiographyC M Otto, A S Pearlman, C D Kraft, et al.British Journal of Pharmacology|December 1, 1995
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040C J Gardner, D J Twissell, T J Dale, et al.Regulatory Peptides|August 27, 1996
GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activityC J Gardner, D R Armour, D T Beattie, et al.British Journal of Pharmacology|January 1, 1994
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonistA Hilditch, A A Hunt, C J Gardner, et al.Neurology|February 9, 2007
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathyM A Nagel, B Forghani, R Mahalingam, et al.Journal of Medicinal Chemistry|July 3, 1998
Design of a new class of orally active fibrinogen receptor antagonistsS I Klein, B F Molino, M Czekaj, et al.Pageof 3